Drug intelligence / Profile preview

ls301

Development stage
Phase 2
Lead developer
Integro Theranostics
Modality
Peptide-Drug Conjugates → Peptide Conjugates → Peptides, Small Molecules
Administration
Intravenous
01

Overview

LS301 is a hydrophobic near-infrared (NIR) fluorescent probe composed of a NIR fluorescent dye (cypate) linked to an unnatural D-cysteine-containing cyclic octapeptide. It is developed as a fluorescence imaging agent for intraoperative visualization of tumors. The compound selectively binds to phosphorylated annexin A2 (pANXA2), which is overexpressed in various solid tumors and tumor-associated stromal cells. This selective binding allows for the delineation of tumor margins and improved accuracy during surgical resection. LS301 has been investigated primarily for image-guided surgery in breast cancer and lung cancer, with additional preclinical studies in gynecological cancers and other solid tumors. The developer is Integro Theranostics[1][2][4][5][7].

Other names
fluorescent dye LS301cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH
02

Targets

ANXA2 (Annexin A2)ANXA3

Beyond the preview

Go deeper on ls301.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ls301.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call